A common feature of cystic fibrosis (CF) is the chronic Pseudomonas aeruginosa pulmonary infection which contributes to the morbidity and mortality of these patients (20) . The confinement of this infection to the lungs suggests a local immune response defect (18) . Serum from CF patients with chronic P. aeruginosa pulmonary infection inhibited the in vitro phagocytosis of P. aeruginosa by both normal (15, 18) and CF alveolar macrophages (18) . However, CF macrophage phagocytosis was unimpaired in the presence of normal serum (18) . When CF and normal sera were mixed together in the phagocytic assay, the inhibition remained (15) . This suggested a blocking activity rather than a deficiency in CF serum. The inhibition was specific for P. aeruginosa since phagocytosis of Serratia marcescens and Staphylococcus aureus was unimpaired (15) . The observed specificity suggested that inhibition was antibody mediated. Receptors for immunoglobulin M (IgM) have not been demonstrated on human alveolar macrophages (7) . Although IgG receptors are known to be present on human alveolar macrophages (7), IgG subclass-specific receptors have not been described. However, IgGl and IgG3 have been shown to bind strongly to human monocytes, whereas IgG2 and IgG4 bind weakly (1, 3) . Thus, it is possible that nonopsonic IgG subclass antibodies, directed to P. aeruginosa antigens, could interfere with macrophage phagocytosis. Fick et al. (2) have demonstrated that P. aeruginosa lipopolysaccharide (LPS)-specific IgG obtained from the serum of chronically infected CF patients inhibits the ability of alveolar macrophages to phagocytize P. aeruginosa.
Previous work has shown that cats immunized with P.
aeruginosa LPS develop phagocytosis-inhibitory activity in their sera (12) . This observation also suggested that chronic LPS exposure, resulting from P. aeruginosa infection, might be important in the development of phagocytosis-inhibitory activity in the serum of CF patients. The present study provides evidence that as a result of chronic pulmonary infection with P. aeruginosa CF patients produce nonopsonic IgG subclasses directed to LPS, concurrent with the development of phagocytosis-inhibitory activity.
MATERIALS AND METHODS
Selection of patients. CF patients of both sexes were selected based on their P. aeruginosa culture history. The noncolonized group consisted of 10 CF patients, ranging in age from 1 (4) .
RESULTS
Serum samples from CF patients colonized with P. aeruginosa and those not colonized (as determined by culture history) were compared. For both groups, the total IgG concentration was determined. In addition, specific subclass antibodies to P. aeruginosa LPS and the level of phagocytosis of P. aeruginosa by normal alveolar macrophages in the presence of the same serum samples was evaluated. In this way, the IgG subclasses directed to LPS and the effect of the serum on phagocytosis could be related.
Total IgG and IgG subclass concentrations. The concentration of each IgG subclass in the serum of colonized and noncolonized patients was determined by radial immunodiffusion ( Table 1 IgGl were present in only 2 of 10 colonized patients (Table  2 ). All patients had antibodies to LPS type 6 in IgG subclasses 2, 3, and 4. Serotyping showed that four of seven patients for whom isolates were available from before the serum collection date had documented colonization with P. aeruginosa serotype 6.
The possibility that the monoclonal antibody used could not detect IgGl bound to LPS was examined. Since most individuals have been vaccinated against diphtheria and tetanus, diphtheria and tetanus toxoids were used as antigens in the same ELISA procedure. Five of five serum samples from normal volunteers had IgGl antibodies to the toxoids (titer, .1:20), thus confirming the functionality of the monoclonal anti-IgGl.
CF patients without P. aeruginosa infection had essentially no IgG antibodies specific for LPS type 6 (Table 3 ). Only 4 of 10 patients tested had IgG4 titers; only one of these four also had an IgG3 titer of 1:20. No patient had detectable levels of IgGl or IgG2 (data not shown). Statistical analysis with the Mann-Whitney test was used for comparisons of the log titer between groups. Subclass levels for IgG2, IgG3, and IgG4 for colonized and noncolonized patients were statistically different (P < 0.001). IgGl was not different between the two groups. These results were similar to those obtained with sera from five normal individuals who had no LPS type 6-specific IgG antibodies of any subclass.
Phagocytosis. Sera from the chronically infected patients (Table 2 ) all showed phagocytosis inhibition of 50% or greater with a mean of 56 + 4%. This was highly significant in comparison to the noncolonized and normal groups (P < 0.005).
Sera from the noncolonized CF patients showed little inhibition or an enhancement of macrophage phagocytosis of P. aeruginosa ( (21) as well as bacterial polysaccharides (13) are primarily IgG2. Carbohydrates from group A streptococci stimulate the production of VOL. 23, 1986 on July 6, 2017 by guest http://jcm.asm.org/
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IgG2 and IgG3 (8) . P. aeruginosa-colonized CF patients have been reported to have elevated levels of IgG4, although the antigen(s) to which the IgG4 was directed was not defined (5) .
Although there were elevated titers of IgG subclasses 2, 3, and 4 directed to LPS in the serum of the colonized patients, the individual IgG subclass concentrations were predominantly within normal subclass ranges for pediatric and adult populations as reported by Oxelius (6) . Among serum samples from the colonized patient group, only 4 of 36 subclass levels were outside the normal range. The levels of IgG4 in the colonized CF patients were comparable to those concentrations reported by Oxelius (6) and Schur et al. (9) for age-matched normal individuals. In contrast, Shakib et al. (10, 11) reported elevated IgG4 levels in 7 of 16 CF patients, but the baseline levels of IgG4 in his normal population were lower than those of Oxelius (6) and Schur et al. (9) . As a result, the significance of the reported elevated IgG4 concentrations in colonized CF patients is unclear. From our study, it appears that in the sera of P. aeruginosa-colonized patients, no single subclass is consistently elevated or depressed in spite of antibody responses against P. aeruginosa LPS. In serum samples from noncolonized patients, 9 of 40 subclass determinations were outside the normal range. However, no consistent pattern in the deviations could be detected, and some normal individuals also had subclass levels outside the normal range.
The total IgG concentration in the serum of the CF patients was determined by radial immunodiffusion and compared with age-matched normal values. Only two patients had elevated total IgG, one patient in the colonized group and one in the noncolonized group.
Sera with high LPS-specific IgG2, IgG3, and IgG4 titers also contained phagocytosis-inhibitory activity. Fick et al. (2) proposed that the phagocytosis-inhibitory activity of CF sera is due to a defect in the Fc portion of P. aeruginosaspecific IgG, and this prevents proper receptor attachment and internalization by macrophages. However, these same investigators also postulated that an alteration in the normal ratio of IgG subclasses may affect phagocytosis. The necessary ratio of opsonic to nonopsonic subclasses for phagocytic enhancement or inhibition is unknown, and further work with combinations of individual subclasses will be required to explore this fully. Other workers have proposed that enhanced titers of IgG4 directed to P. aeruginosa antigens are responsible for the phagocytic inhibition (5). Our results suggest that the presence of nonopsonic IgG2 and IgG4 directed to LPS may decrease the effectiveness of macrophage phagocytosis of P. aeruginosa. It is possible that these nonopsonic antibodies compete with opsonic IgG3 (since IgGl levels versus LPS are low or absent), thus coating the bacteria with enough nonopsonic antibody to inhibit phagocytosis.
